Thus, it has been seen that the administration of ABX-IL-8 to mice carrying xenografts of bladder cancer decreases their tendency to metastasize and progress [18], as also happens in similar models of melanoma and prostate cancer [19]. Here, CXCL8 is linked to urinary bladder cancer.